Literature DB >> 21573881

Change in comorbidity prevalence with advancing age among persons with heart failure.

Sangeeta C Ahluwalia1, Cary P Gross, Sarwat I Chaudhry, Linda Leo-Summers, Peter H Van Ness, Terri R Fried.   

Abstract

BACKGROUND: Comorbidity-a condition that co-exists with a primary illness-is common among older persons with heart failure and can complicate the overall management of this population.
OBJECTIVES: To determine the relationship between advancing age and the prevalence and patterns of comorbidity among older persons with heart failure.
DESIGN: Retrospective longitudinal cohort study PARTICIPANTS: A total of 201,130 Medicare beneficiaries with heart failure stratified into three age strata in 2001: 66-75, 76-85, and 86+ years, and followed over 5 years. MEASUREMENTS: (1) Prevalence of 19 conditions as identified by the Chronic Conditions Warehouse from Medicare claims data, characterized as concordant (related to heart failure) or discordant (unrelated to heart failure), and (2) overall comorbidity burden, defined as count of conditions.
RESULTS: The median number of comorbidities rose from four (IQR: 2-5) to five (IQR: 4-7) among the young-old, and from 4 (IQR: 3-6) to 6 (IQR: 5-8) among the middle-old and oldest-old between 2001 and 2006. In 2001, the majority of concordant conditions were more prevalent among the youngest than oldest beneficiaries (e.g., diabetes 46.2% vs 26.9%; kidney disease 21.8% vs 18.4%), while the majority of discordant conditions were more prevalent among the oldest-old than youngest-old beneficiaries (e.g., dementia 39.6% vs 9.9%; hip fracture 9.5% vs 1.9%). Discordant conditions increased in prevalence faster among the oldest than youngest beneficiaries (e.g., dementia 13% points versus 9% points).
CONCLUSION: Among older Medicare beneficiaries with heart failure, there is a higher overall burden of comorbidity and greater prevalence of discordant comorbidity among the oldest old. Comorbidity prevalence increases over time, with discordant comorbidity increasing at the fastest rate among the oldest old. This comorbidity burden highlights the challenge of effectively treating heart failure while simultaneously managing co-existing and unrelated conditions.

Entities:  

Mesh:

Year:  2011        PMID: 21573881      PMCID: PMC3181289          DOI: 10.1007/s11606-011-1725-6

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  41 in total

1.  Prevalence, expenditures, and complications of multiple chronic conditions in the elderly.

Authors:  Jennifer L Wolff; Barbara Starfield; Gerard Anderson
Journal:  Arch Intern Med       Date:  2002-11-11

2.  Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure: too many cooks will spoil the broth.

Authors:  John G F Cleland; Andrew L Clark
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

3.  Polypharmacy and comorbidity in heart failure.

Authors:  Frederick A Masoudi; Harlan M Krumholz
Journal:  BMJ       Date:  2003-09-06

4.  The treatment of unrelated disorders in patients with chronic medical diseases.

Authors:  D A Redelmeier; S H Tan; G L Booth
Journal:  N Engl J Med       Date:  1998-05-21       Impact factor: 91.245

5.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Authors:  Salim Yusuf; Bertram Pitt; Clarence E Davis; William B Hood; Jay N Cohn
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

6.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.

Authors:  J N Cohn; G Johnson; S Ziesche; F Cobb; G Francis; F Tristani; R Smith; W B Dunkman; H Loeb; M Wong
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

7.  Role of diabetes in congestive heart failure: the Framingham study.

Authors:  W B Kannel; M Hjortland; W P Castelli
Journal:  Am J Cardiol       Date:  1974-07       Impact factor: 2.778

8.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors:  K Swedberg; J Kjekshus
Journal:  Am J Cardiol       Date:  1988-07-11       Impact factor: 2.778

9.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

Authors:  M Packer; M R Bristow; J N Cohn; W S Colucci; M B Fowler; E M Gilbert; N H Shusterman
Journal:  N Engl J Med       Date:  1996-05-23       Impact factor: 91.245

10.  Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure.

Authors:  Joel B Braunstein; Gerard F Anderson; Gary Gerstenblith; Wendy Weller; Marlene Niefeld; Robert Herbert; Albert W Wu
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

View more
  28 in total

1.  Comorbidity and polypharmacy in chronic heart failure: a large cross-sectional study in primary care.

Authors:  Bosco Baron-Franco; Gary McLean; Frances S Mair; Veronique L Roger; Bruce Guthrie; Stewart W Mercer
Journal:  Br J Gen Pract       Date:  2017-04-10       Impact factor: 5.386

Review 2.  Decision-making under uncertainty in advanced heart failure.

Authors:  Theo E Meyer; Michael S Kiernan; David D McManus; Jeffrey Shih
Journal:  Curr Heart Fail Rep       Date:  2014-06

Review 3.  Ace inhibitor therapy for heart failure in patients with impaired renal function: a review of the literature.

Authors:  Ali A Valika; Mihai Gheorghiade
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

4.  Early and Long-term Outcomes of Older Adults after Acute Care Encounters for Chronic Obstructive Pulmonary Disease Exacerbation.

Authors:  Liza Genao; Michael T Durheim; Xiaojuan Mi; Jamie L Todd; Heather E Whitson; Lesley H Curtis
Journal:  Ann Am Thorac Soc       Date:  2015-12

5.  Treatment Effectiveness in Heart Failure with Comorbidity: Lung Disease and Kidney Disease.

Authors:  Jerry H Gurwitz; David J Magid; David H Smith; Grace H Tabada; Sue Hee Sung; Larry A Allen; David D McManus; Robert J Goldberg; Mayra Tisminetzky; Alan S Go
Journal:  J Am Geriatr Soc       Date:  2017-09-05       Impact factor: 5.562

6.  All-Payer Analysis of Heart Failure Hospitalization 30-Day Readmission: Comorbidities Matter.

Authors:  Jonathan D Davis; Margaret A Olsen; Kerry Bommarito; Shane J LaRue; Mohammed Saeed; Michael W Rich; Justin M Vader
Journal:  Am J Med       Date:  2016-08-31       Impact factor: 4.965

7.  Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction.

Authors:  Jerry H Gurwitz; David J Magid; David H Smith; Robert J Goldberg; David D McManus; Larry A Allen; Jane S Saczynski; Micah L Thorp; Grace Hsu; Sue Hee Sung; Alan S Go
Journal:  Am J Med       Date:  2013-03-14       Impact factor: 4.965

8.  Patterns of comorbidity in older adults with heart failure: the Cardiovascular Research Network PRESERVE study.

Authors:  Jane S Saczynski; Alan S Go; David J Magid; David H Smith; David D McManus; Larry Allen; Jessica Ogarek; Robert J Goldberg; Jerry H Gurwitz
Journal:  J Am Geriatr Soc       Date:  2013-01       Impact factor: 5.562

Review 9.  Heart failure as a risk factor for osteoporosis and fractures.

Authors:  Aloice O Aluoch; Ryan Jessee; Hani Habal; Melinda Garcia-Rosell; Rehan Shah; Guy Reed; Laura Carbone
Journal:  Curr Osteoporos Rep       Date:  2012-12       Impact factor: 5.096

10.  Comparing comorbidity measures and fatigue post myocardial infarction.

Authors:  Carolyn E Horne; Sharona Johnson; Patricia B Crane
Journal:  Appl Nurs Res       Date:  2018-11-07       Impact factor: 2.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.